戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y to form tube-like structures on collagen ("vasculogenic mimicry").
2 vascular channels without EC, referred to as vasculogenic mimicry.
3 noma mitogen, laminin, a phenomenon known as vasculogenic mimicry.
4 ell dissemination by increasing invasion and vasculogenic mimicry.
5  cell invasion, migration, and inhibition of vasculogenic mimicry.
6 ddition to tumor cell plasticity as shown by vasculogenic mimicry.
7  adapted to a pseudoendothelial phenotype in vasculogenic mimicry.
8 sis that VE-cadherin is critical in melanoma vasculogenic mimicry.
9 in tyrosine kinases are involved in melanoma vasculogenic mimicry.
10 may not be applicable to tumors that express vasculogenic mimicry.
11 MP2, ultimately leading to the inhibition of vasculogenic mimicry.
12 on, invasion, adhesion, colony formation and vasculogenic mimicry.
13              In addition, Notch4 function in vasculogenic mimicry and anchorage-independent growth in
14  an essential role during the acquisition of vasculogenic mimicry and angiogenic properties associate
15 events that regulate the process of melanoma vasculogenic mimicry and identify new signal transductio
16 he ability of these tumor cells to engage in vasculogenic mimicry and neovascularization.
17  overexpressed in glioma, glioma stem cells, vasculogenic mimicry and neovasculature.
18 osome nucleation, motility, neoangiogenesis, vasculogenic mimicry, and osteoclastogenesis in the abse
19      MEF2C was found to mediate VEGF-induced vasculogenic mimicry, angiogenesis and migration/invasio
20 lial-cadherin, which plays a pivotal role in vasculogenic mimicry, as well as interleukin-8, fibronec
21 /or its cleavage fragments, are required for vasculogenic mimicry by aggressive melanoma cells.
22 In this study, we found that BPIFB1 inhibits vasculogenic mimicry by regulating the metabolic reprogr
23 y human melanoma cells in vivo and in vitro: vasculogenic mimicry," by Maniotis and colleagues, which
24                                              Vasculogenic mimicry describes a process where aggressiv
25 tumors because of their ability to implement vasculogenic mimicry during hypoxia.
26 erized to invade aggressively and to undergo vasculogenic mimicry, expressed Mig-7.
27                          Recently, the term "vasculogenic mimicry" has been used by our laboratory an
28 r gene involved in regulating glycolysis and vasculogenic mimicry in NPC.
29                                              Vasculogenic mimicry is posited to contribute to melanom
30 lular and molecular determinants of melanoma vasculogenic mimicry is presented.
31                     These data indicate that vasculogenic mimicry-like laminin networks, in addition
32    Mig-7 protein primarily co-localized with vasculogenic mimicry markers factor VIII-associated anti
33 EF2C on cell proliferation, and VEGF-induced vasculogenic mimicry, migration/invasion as well as angi
34  aggressive melanoma cells to participate in vasculogenic mimicry, particularly their expression of e
35 highly invasive uveal melanoma cells forming vasculogenic mimicry patterns after exposure to a lamini
36  tissue samples, uveal melanoma cells within vasculogenic mimicry patterns assumed the spindle A morp
37 s of primary uveal melanomas lacking looping vasculogenic mimicry patterns either did not stain for o
38   The histological detection of laminin-rich vasculogenic mimicry patterns in human primary uveal mel
39 on of human rather than mouse laminin in the vasculogenic mimicry patterns in this model demonstrates
40                      Thus, the generation of vasculogenic mimicry patterns is accompanied by dampenin
41                                              Vasculogenic mimicry patterns were reconstructed from se
42 highly invasive uveal melanoma cells forming vasculogenic mimicry patterns, and genes associated with
43                                              Vasculogenic mimicry patterns, composed of human laminin
44      In primary melanomas containing looping vasculogenic mimicry patterns, strong osteopontin staini
45                                After forming vasculogenic mimicry patterns, uveal melanoma cells inva
46                           Imaging revealed a vasculogenic mimicry phenotype in NGFR(hi) tumor cells w
47 ith their increased invasion, migration, and vasculogenic mimicry plasticity.
48 echanical and molecular events that regulate vasculogenic mimicry provide opportunities for the devel
49      The unique patterning characteristic of vasculogenic mimicry provides an opportunity to design n
50 an carcinoma cells could engage in molecular vasculogenic mimicry reflected by their plasticity, comp
51 l of histone and decreases the expression of vasculogenic mimicry-related genes, VEGFA, VE-cadherin,
52         We recently have introduced the term vasculogenic mimicry to describe the unique ability of a
53 egulated, aggressive tumor cells was termed "vasculogenic mimicry" to emphasize their de novo generat
54                                              Vasculogenic mimicry (VM) describes the unique ability o
55 er (NSCLC), its linkage to alteration of the vasculogenic mimicry (VM) formation to influence the NSC
56                                              Vasculogenic mimicry (VM) is a recently discovered angio
57        A growing body of evidence shows that vasculogenic mimicry (VM) is closely related to the inva
58                                              Vasculogenic mimicry (VM) is the phenomenon whereby non-
59 s found in patient tumor slices displaying a vasculogenic mimicry (VM) phenotype.
60                                   Tumor cell vasculogenic mimicry (VM) refers to the plasticity of ag
61 l cell carcinoma (ccRCC), its role to impact vasculogenic mimicry (VM) to alter the ccRCC progression
62 E-cadherin) and cytokeratins consistent with vasculogenic mimicry (VM), a process whereby tumour cell
63  display the ability to drive blood-perfused vasculogenic mimicry (VM), an alternative microvascular
64 in) and TIE1 and are associated with CD31(-) vasculogenic mimicry (VM), an established biomarker asso
65 alpha expression and an increase in CD144(+) vasculogenic mimicry (VM), leading to formation of chann
66                                              Vasculogenic mimicry (VM), the formation of matrix-rich
67 -2 expression with known prognostic factors, vasculogenic mimicry (VM), the mature vasculature (von W
68 nd participate in a PECAM1-dependent form of vasculogenic mimicry (VM).
69 ng vessel-like channels, a phenomenon termed vasculogenic mimicry (VM).
70 ternative microvascular circulation known as vasculogenic mimicry (VM).
71 remodeling to form the specific mechanism of vasculogenic mimicry; we also summarized some of the cur
72 rs have recently described a process termed "vasculogenic mimicry," which consists of the formation o